Synapse

← Adrian L. Harris

Papers by Adrian L. Harris

Page 9 · newest first

  1. Novel Mechanism of Action for HydralazineCirculation Research · 2004
  2. Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancerBritish Journal of Cancer · 2004
  3. Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor α and Improved Survival in Primary Human Breast CarcinomasClinical Cancer Research · 2004
  4. Activation of Peroxisome Proliferator-Activated Receptor δ Stimulates the Proliferation of Human Breast and Prostate Cancer Cell LinesCancer Research · 2004
  5. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxiaBritish Journal of Cancer · 2004
  6. Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCRBritish Journal of Cancer · 2004
  7. Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target geneBritish Journal of Cancer · 2004
  8. Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleusThe Journal of Pathology · 2004
  9. Non‐linear survival analysis using neural networksStatistics in Medicine · 2004
  10. Hypoxia Inducible Carbonic Anhydrase IX, Marker of Tumour: Hypoxia, Survival Pathway and Therapy TargetCell Cycle · 2004
  11. Novel Angiogenic Signaling Pathways and Vascular TargetsThe Annual Review of Pharmacology and Toxicology · 2004
  12. Macrophage Infiltration and Angiogenesis in Human Malignancy2004
  13. Copper Chelation as an Antiangiogenic TherapyOncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2004
  14. Hypoxia-inducible factors and hypoxic cell death in tumour physiologyAnnals of Medicine · 2004
  15. Expression of the cell death genes BNip3 and NIX in ductal carcinoma in situ of the breast; correlation of BNip3 levels with necrosis and gradeThe Journal of Pathology · 2003
  16. Anoxic induction of ATF-4 through HIF-1–independent pathways of protein stabilization in human cancer cellsBlood · 2003
  17. NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic CellsThe Journal of Immunology · 2003
  18. Cytoplasmic p21 WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosisBreast Cancer Research · 2003
  19. Angiogenesis in Endocrine TumorsEndocrine Reviews · 2003
  20. A multicentre phase II trial of bryostatin-1 in patients with advanced renal cancerENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2003
  21. High-dose i.v. granisetron for the prevention of chemotherapy-induced emesis: cardiac safety and tolerabilityAnti-Cancer Drugs · 2003
  22. Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agentsBritish Journal of Cancer · 2003
  23. Hypoxia-inducible factors 1?? and 2?? are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skinMelanoma Research · 2003
  24. Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentationBritish Journal of Cancer · 2003
  25. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosisBritish Journal of Cancer · 2003
  26. A phase 1 study of tazarotene in adults with advanced cancerBritish Journal of Cancer · 2003
  27. Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences · 2003
  28. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancerBritish Journal of Cancer · 2003
  29. Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxaneBritish Journal of Cancer · 2003
  30. A population pharmacokinetic model for paclitaxel in the presence of a novel P‐gp modulator, Zosuquidar Trihydrochloride (LY335979)British Journal of Clinical Pharmacology · 2003
  31. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical studyHistopathology · 2003
  32. Cutaneous breast cancer deposits show distinct growth patterns with different degrees of angiogenesis, hypoxia and fibrin depositionHistopathology · 2003
  33. Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritisArthritis Research & Therapy · 2003
  34. Vascular Patterns in Glioblastoma Influence Clinical Outcome and Associate with Variable Expression of Angiogenic Proteins: Evidence for Distinct Angiogenic SubtypesBrain Pathology · 2003
  35. Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinomaBritish Journal of Cancer · 2003
  36. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancerThe Journal of Pathology · 2003
  37. Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expressionBritish Journal of Cancer · 2003
  38. DEC1 (STRA13) protein expression relates to hypoxia‐ inducible factor 1‐alpha and carbonic anhydrase‐9 overexpression in non‐small cell lung cancerThe Journal of Pathology · 2003
  39. Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical CancerJournal of Biological Chemistry · 2003
  40. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycanBritish Journal of Cancer · 2003
  41. Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphomaBritish Journal of Cancer · 2003
  42. Carbonic Anhydrase IX Expression, a Novel Surrogate Marker of Tumor Hypoxia, Is Associated With a Poor Prognosis in Non–Small-Cell Lung CancerFaculty of Health; Institute of Health and Biomedical Innovation · 2003
  43. GLUT‐1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole bindingInternational Journal of Cancer · 2003
  44. Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor TypesJournal of Clinical Oncology · 2002
  45. Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxiaThe Journal of Pathology · 2002
  46. Hypoxia‐induced pathways in breast cancerMicroscopy Research and Technique · 2002
  47. Preparation of the iodine‐124 derivative of the Bolton–Hunter reagent ([124I]I‐SHPP) and its use for labelling a VEGF antibody as a PET tracerJournal of Labelled Compounds and Radiopharmaceuticals · 2002
  48. Association of hypoxia‐inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinomaCancer · 2002
  49. Thymidine Phosphorylase Expression in Gallbladder AdenocarcinomasInternational Journal of Surgical Pathology · 2002
  50. Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c‐erbB2The Journal of Pathology · 2002